Cargando…

Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic

PURPOSE: An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Arndt, Volker, Doege, Daniela, Fröhling, Stefan, Albers, Peter, Algül, Hana, Bargou, Ralf, Bokemeyer, Carsten, Bornhäuser, Martin, Brandts, Christian H., Brossart, Peter, Brucker, Sara Yvonne, Brümmendorf, Tim H., Döhner, Hartmut, Gattermann, Norbert, Hallek, Michael, Heinemann, Volker, Keilholz, Ulrich, Kindler, Thomas, von Levetzow, Cornelia, Lordick, Florian, Neumann, Ulf Peter, Peters, Christoph, Schadendorf, Dirk, Stilgenbauer, Stephan, Zander, Thomas, Zips, Daniel, Braun, Delia, Seufferlein, Thomas, Nettekoven, Gerd, Baumann, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568964/
https://www.ncbi.nlm.nih.gov/pubmed/36241862
http://dx.doi.org/10.1007/s00432-022-04407-1
_version_ 1784809760959234048
author Arndt, Volker
Doege, Daniela
Fröhling, Stefan
Albers, Peter
Algül, Hana
Bargou, Ralf
Bokemeyer, Carsten
Bornhäuser, Martin
Brandts, Christian H.
Brossart, Peter
Brucker, Sara Yvonne
Brümmendorf, Tim H.
Döhner, Hartmut
Gattermann, Norbert
Hallek, Michael
Heinemann, Volker
Keilholz, Ulrich
Kindler, Thomas
von Levetzow, Cornelia
Lordick, Florian
Neumann, Ulf Peter
Peters, Christoph
Schadendorf, Dirk
Stilgenbauer, Stephan
Zander, Thomas
Zips, Daniel
Braun, Delia
Seufferlein, Thomas
Nettekoven, Gerd
Baumann, Michael
author_facet Arndt, Volker
Doege, Daniela
Fröhling, Stefan
Albers, Peter
Algül, Hana
Bargou, Ralf
Bokemeyer, Carsten
Bornhäuser, Martin
Brandts, Christian H.
Brossart, Peter
Brucker, Sara Yvonne
Brümmendorf, Tim H.
Döhner, Hartmut
Gattermann, Norbert
Hallek, Michael
Heinemann, Volker
Keilholz, Ulrich
Kindler, Thomas
von Levetzow, Cornelia
Lordick, Florian
Neumann, Ulf Peter
Peters, Christoph
Schadendorf, Dirk
Stilgenbauer, Stephan
Zander, Thomas
Zips, Daniel
Braun, Delia
Seufferlein, Thomas
Nettekoven, Gerd
Baumann, Michael
author_sort Arndt, Volker
collection PubMed
description PURPOSE: An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic. METHODS: Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022. RESULTS: The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (− 21%) and psycho-oncologic care (− 12%), but also tumor surgery (− 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care. CONCLUSIONS: This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future.
format Online
Article
Text
id pubmed-9568964
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-95689642022-10-16 Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic Arndt, Volker Doege, Daniela Fröhling, Stefan Albers, Peter Algül, Hana Bargou, Ralf Bokemeyer, Carsten Bornhäuser, Martin Brandts, Christian H. Brossart, Peter Brucker, Sara Yvonne Brümmendorf, Tim H. Döhner, Hartmut Gattermann, Norbert Hallek, Michael Heinemann, Volker Keilholz, Ulrich Kindler, Thomas von Levetzow, Cornelia Lordick, Florian Neumann, Ulf Peter Peters, Christoph Schadendorf, Dirk Stilgenbauer, Stephan Zander, Thomas Zips, Daniel Braun, Delia Seufferlein, Thomas Nettekoven, Gerd Baumann, Michael J Cancer Res Clin Oncol Letter to the Editor PURPOSE: An increasing number of international studies demonstrate serious negative effects of the COVID-19 pandemic on the timely diagnosis of cancer and on cancer treatment. Our study aimed to quantitatively and qualitatively evaluate the capacities of German Comprehensive Cancer Centers (CCCs) in different areas of complex oncology care during the first 2 years of the COVID-19 pandemic. METHODS: Prospective panel survey over 23 rounds among 18 CCCs in Germany between March 2020 and June 2022. RESULTS: The COVID-19 pandemic substantially affected the oncological care system in Germany during the first 2 years. Persistent limitations of care in CCCs primarily affected follow-up (− 21%) and psycho-oncologic care (− 12%), but also tumor surgery (− 9%). Substantial limitations were also reported for all other areas of multidisciplinary oncological care. CONCLUSIONS: This study documents the limitations of oncological care during the COVID-19 pandemic and highlights the need to develop strategies to avoid similar limitations in the future. Springer Berlin Heidelberg 2022-10-14 2023 /pmc/articles/PMC9568964/ /pubmed/36241862 http://dx.doi.org/10.1007/s00432-022-04407-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter to the Editor
Arndt, Volker
Doege, Daniela
Fröhling, Stefan
Albers, Peter
Algül, Hana
Bargou, Ralf
Bokemeyer, Carsten
Bornhäuser, Martin
Brandts, Christian H.
Brossart, Peter
Brucker, Sara Yvonne
Brümmendorf, Tim H.
Döhner, Hartmut
Gattermann, Norbert
Hallek, Michael
Heinemann, Volker
Keilholz, Ulrich
Kindler, Thomas
von Levetzow, Cornelia
Lordick, Florian
Neumann, Ulf Peter
Peters, Christoph
Schadendorf, Dirk
Stilgenbauer, Stephan
Zander, Thomas
Zips, Daniel
Braun, Delia
Seufferlein, Thomas
Nettekoven, Gerd
Baumann, Michael
Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
title Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
title_full Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
title_fullStr Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
title_full_unstemmed Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
title_short Cancer care in German centers of excellence during the first 2 years of the COVID-19 pandemic
title_sort cancer care in german centers of excellence during the first 2 years of the covid-19 pandemic
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568964/
https://www.ncbi.nlm.nih.gov/pubmed/36241862
http://dx.doi.org/10.1007/s00432-022-04407-1
work_keys_str_mv AT arndtvolker cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT doegedaniela cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT frohlingstefan cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT alberspeter cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT algulhana cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT bargouralf cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT bokemeyercarsten cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT bornhausermartin cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT brandtschristianh cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT brossartpeter cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT bruckersarayvonne cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT brummendorftimh cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT dohnerhartmut cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT gattermannnorbert cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT hallekmichael cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT heinemannvolker cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT keilholzulrich cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT kindlerthomas cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT vonlevetzowcornelia cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT lordickflorian cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT neumannulfpeter cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT peterschristoph cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT schadendorfdirk cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT stilgenbauerstephan cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT zanderthomas cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT zipsdaniel cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT braundelia cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT seufferleinthomas cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT nettekovengerd cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic
AT baumannmichael cancercareingermancentersofexcellenceduringthefirst2yearsofthecovid19pandemic